Becton, **** inson and Company (BDX) develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products. Valued at $50.5 billion by market cap, the company offers solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, and promote infection prevention.
Shares of this global medical technology giant have underperformed the broader market over the past year. BDX has gained 19.6% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 20.4%. However, in 2026, BDX stock is up 20.2%, surpassing the SPX's 13.7% rise on a YTD basis.
CoreWeave vs Nebius: Both Companies Reported Strong Earnings, But Here's the Stock You Should Buy
A $210 Billion Reason to Buy AMD Stock Here
As Oracle Deepens Its Partnership with AWS, Here's How You Should Play ORCL Stock
#medical #billion
Shares of this global medical technology giant have underperformed the broader market over the past year. BDX has gained 19.6% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 20.4%. However, in 2026, BDX stock is up 20.2%, surpassing the SPX's 13.7% rise on a YTD basis.
CoreWeave vs Nebius: Both Companies Reported Strong Earnings, But Here's the Stock You Should Buy
A $210 Billion Reason to Buy AMD Stock Here
As Oracle Deepens Its Partnership with AWS, Here's How You Should Play ORCL Stock
#medical #billion
2 days ago
